Clinical Trial Update: Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 4]

View source ↗

Summary

This is a completed Phase 4 clinical trial update evaluating interleukin-2 in patients with metastatic renal cell carcinoma (kidney cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Kidney Cancer | Phase 4 | Status: COMPLETED